[Skip to Content]
[Skip to Content Landing]
Views 956
Citations 0
Invited Commentary
February 2017

Demonstrating the Effectiveness of Low-Vision Rehabilitation With Outcomes of the Veterans Affairs Low Vision Intervention Trial II (LOVIT II)

Author Affiliations
  • 1UCL (University College London) Institute of Ophthalmology, London, United Kingdom

Copyright 2016 American Medical Association. All Rights Reserved.

JAMA Ophthalmol. 2017;135(2):105-106. doi:10.1001/jamaophthalmol.2016.4778

Severe visual impairment, partial sight, or low vision (LV)—call it what you like, the long-term reduction in visual function takes a large toll on the affected individuals, their families, and society in general. Loss of independence, unemployment, depression, and increased mortality and morbidity all contribute to a diminished quality of life that characterizes LV. The total annual cost of low vision in the United States is estimated to be $5.5 billion plus an additional $10 billion due to lost quality-adjusted life years.1

First Page Preview View Large
First page PDF preview
First page PDF preview